EIAP Announces Successes from First Two Cohorts

August 10, 2023, by CRCHD Staff

The Center to Reduce Cancer Health Disparities and the Early Investigator Advancement Program (EIAP) are thrilled to to announce the tremendous accomplishments of EIAP Scholars from Cohorts I and II who have attained an R01 or equivalent award!

 

 

Dr. Laurie E. McLouth was awarded the Cancer Moonshot Scholars R01 for her application titled, Pathways, a Hope-Based Intervention to Support Personal Goal Pursuit, Mental Health, and Quality of Life during Advanced Lung Cancer Treatment, through the National Cancer Institute (NCI).

 

 

 

 

 

Dr. Jose Alejandro Rauh-Hain was awarded the NIH Research Project Grant R01 for his application titled, Health Equity in Fertility Specialty Care Among Cancer Survivors, through the National Institute on Minority Health and Health Disparities (NIMHD). Dr. Rauh-Hain is a former CURE recipient (K08).

 

 

 

 

 

 

Dr. Huy Q. Dinh was awarded the Maximizing Investigators' Research Award (MIRA) R35 for his application titled, Neutrophil Heterogeneity and Plasticity in Wound Healing, through the National Institute of General Medical Sciences (NIGMS).

 

 

 

 

 

 

 

Dr. Hatice U. Osmanbeyoglu reached research independence after being awarded the MIRA R35 award for her application titled, Computational Methods for Delineating Cell Context-specific Regulatory Programs, through NIGMS.

 

 

 

 

 

 

Dr. Cristina Zavaleta received the New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research R01 for her application titled, A New Multimodal Molecular Imaging Approach to Guide Intra-Operative Tumor Resection and Post-Operative Treatment Planning, through the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Dr. Zavaleta is a two-time former CURE recipient (K22 and R21) and served as Chair of CRCHD’s annual Mock Review in 2015.

We understand the incredible sacrifice it takes for cancer researchers and clinician scientists to work toward this milestone.

The NCI Equity Council launched EIAP in 2021 to facilitate the advancement of scientists from diverse backgrounds to become established investigators. Although EIAP provides essential support, it is the hard work, commitment, and perseverance of the scholars that lead to becoming an established investigator. The nation depends on diverse and creative talents to achieve the NCI’s goals of discovering new ways to advance cancer research and eliminate cancer health disparities. Congratulations to our EIAP Scholars for your achievements and dedication to cancer and cancer health disparities research!